Stomach Cancer clinical trials
Showing 101–150 of 194 active trials. Describe your situation to see which ones you may be eligible for.
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- AMT-116 in Patients With Advanced Solid Tumors
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- CONFIRM: Magnetic Resonance Guided Radiation Therapy
- A Beta-only IL-2 ImmunoTherapY Study
- A Phase 1/1b Study of IAM1363 in HER2 Cancers
- A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
- Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
- [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Intravital Microscopy in Human Solid Tumors
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
- Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers
- Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
- CTNNA1 Familial Expansion Study
- The Gastric Cancer Foundation: A Gastric Cancer Registry
- A Study Collecting Health Information to Understand and Prevent Gastric Cancer
- EsophaCap for the Detection of Early Esophageal Carcinoma
- The GAstric Precancerous Conditions Study
- Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy
- Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
- A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- Pan-tumor MRD Study
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.